12.19.19
Beginning in the second quarter of fiscal 2020, Ashland will change the manner in which it manages the business, moving from a functionally-led organization to a business-unit focused organization.
These changes will enable the company to align its business models, resources and cost structure to the specific needs of each business unit and create greater ownership and accountability for both short- and long-term performance.
Ashland plans to organize around three primary external-reporting segments and a corporate reporting segment. Each primary segment will serve certain business units as outlined below:
The Life Sciences business unit will include Pharma and Health & Wellness.
Specialty Additives will include Coatings and Performance Specialties.
Intermediates & Solvents will report the results of the Lima, Ohio facility.
The Corporate reporting segment will hold corporate governance activities and certain legacy matters.
Ashland plans to implement the core changes during the second quarter of fiscal 2020, aligning resources, leadership teams, operations, incentives, and financial reporting.
Throughout the quarter, the new teams will begin to review and define their respective strategy, business model and cost structure.
The company will provide an update on this process and more detail during its December quarter earnings call in January 2020.
These changes will enable the company to align its business models, resources and cost structure to the specific needs of each business unit and create greater ownership and accountability for both short- and long-term performance.
Ashland plans to organize around three primary external-reporting segments and a corporate reporting segment. Each primary segment will serve certain business units as outlined below:
| Segment | Consumer Specialties | Industrial Specialties | Intermediates & Solvents | Corporate |
| Business Units |
Life Sciences Personal Care & Household |
Specialty Additives Performance Adhesives |
Intermediates & Solvents |
The Life Sciences business unit will include Pharma and Health & Wellness.
Specialty Additives will include Coatings and Performance Specialties.
Intermediates & Solvents will report the results of the Lima, Ohio facility.
The Corporate reporting segment will hold corporate governance activities and certain legacy matters.
Ashland plans to implement the core changes during the second quarter of fiscal 2020, aligning resources, leadership teams, operations, incentives, and financial reporting.
Throughout the quarter, the new teams will begin to review and define their respective strategy, business model and cost structure.
The company will provide an update on this process and more detail during its December quarter earnings call in January 2020.
